External Funding Opportunities
Funding Opportunity |
Deadline |
|
NIH Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01) |
September 15 |
|
September 25 |
|
|
September 25 |
|
|
NIH-NCI Notice of Special Interest (NOSI): Advancing Cancer Data Repositories and Knowledgebases NCI is encouraging the submission of applications to either PAR-20-089 Biomedical Data Repository (U24-Clinical Trial Not Allowed) or PAR-20-097 Biomedical Knowledgebase (U24-Clinical Trial Not Allowed) FOAs, focused on the establishment of new, or continued development of established cancer data resources that use state-of-the-art and cost-effective technologies and approaches, and that are of high value to the broad cancer research community. This NOSI applies to applications for both data repositories and knowledgebases. |
September 25 |
|
NIH-NCI Cancer Research Education Grants Program - Curriculum or Methods Development (R25) The over-arching goal of this NCI R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Curriculum or Methods Development. Applications are encouraged that propose innovative, state-of-the-art programs that address the cause, diagnosis, prevention, or treatment of cancer, rehabilitation from cancer, or the continuing care of cancer patients and the families of cancer patients |
September 25 |
|
October 5 |
|
|
October 5 |
|
|
NIH Notice of Special Interest (NOSI): Obesity Policy Evaluation Research (R01) |
October 5 |
|
NIH Administrative Supplement for Research on Dietary Supplements This FOA announces the availability of administrative supplements to support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention. Parent awards need not be focused on dietary supplements; this FOA may provide support to include dietary supplements within the scope of relevant research projects. Research interests of ODS are not limited to specific health conditions, organ systems or population groups. ODS supports all types of research, including pre-clinical, clinical, behavioral, and epidemiological. |
October 15 |
|
NIH Ethical, Legal and Social Implications (ELSI) Research This FOA invites applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. Proposed approaches may include but are not limited to data-generating qualitative and quantitative approaches, legal, economic and normative analyses, and other types of analytical and conceptual research methodologies, such as those involving the direct engagement of stakeholders. |
October 19 |
|
NIH Fertility Status as a Marker for Overall Health This FOA focuses on studies evaluating fertility as a marker for overall health, and therefore applications that look at the effects of the disease or disorder on fertility are outside of the scope of this program. |
October 19 |
|
NIH Aging, Cancer-Initiating Cells, and Cancer Development (U01) |
October 27 |
|
NIH Investigator-Initiated Research on Genetic Counseling Processes and Practices The purpose of this initiative is to support investigator-initiated research on genetic counseling processes and practices in genomic medicine. Research is needed to optimize the genetic counseling process in the context of limited resources. Applications will assess, innovate, scale, and/or research the implementation of novel genetic counseling practices to address the need for more healthcare professionals trained in genetic counseling; the uneven access to in-person genetic counseling across U.S. health care systems; and the challenges of effective and efficient communication of genomic findings to clinicians, patients, and families. |
October 28 |
|
NIH New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01) |
November 18 |
|
NIH Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18) This FOA invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways—expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. This program requires basic experimental studies with humans. |
March 17, 2021 |
|
NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline: Varies by awarding IC |
Varies |
|
NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought. Deadline: Applies to due dates on or after May 7, 2020 through January 8, 2023 |
Varies |
Funding Opportunity |
Deadline |
|
DOD-CDMRP Pancreatic Cancer Research Program (PCARP) The goal of the PCARP is to diminish the burden of pancreatic cancer among Service members, Veterans, their families, and the American public. The mission of the PCARP is to promote rigorous, innovative, high-impact research that leads to new pancreatic cancer diagnostic and therapeutic tools through collaboration. Mechanisms include: Idea Development Award and Translational Research Partnership Award. |
August 25 – Pre-application; November 20 - Application |
|
Stand Up to Cancer Health Equity Breakthrough Team Research Grant Program |
September 1 – LOI; January 8, 2021 – Full application by invite |
|
On-going |
|
|
NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB) |
On-going |
|
On-going |
|
|
Varies |
|
|
DOD-CDMRP Peer Reviewed Cancer Research Program (PRCRP) The PRCRP is charged by Congress with the mission to investigate cancer risks and knowledge gaps that may be relevant to active duty Service members, their families, other military beneficiaries, and the American public. Mechanisms include: Virtual Cancer Center Director Award; Career Development Award – Fellow Option; Career Development Award – Virtual Cancer Center Scholar Option; Idea Award; Impact Award; Behavioral Health Science Award; and Translational Team Science Award. |
Varies |
|
DOD-CDMRP Lung Cancer Research Program (LCRP) The vision of the FY20 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include: Concept award, Idea development award, and Investigator initiated translational research award. Deadlines: vary by mechanism |
Varies |
|
DOD-CDMRP Breast Cancer Research Program (BCRP) The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. Mechanisms include: Breakthrough Award Levels 1 and 2; Breakthrough Award Level 3; Breakthrough Award Level 4; Era of Hope Scholar Award; Innovator Award; and Transformative Breast Cancer Consortium Award. |
Varies |
|
Damon Runyon Cancer Research Foundation The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research. The foundation provides a variety of cancer-related funding opportunities. Deadline: Varies by opportunity |
Varies |
- Research Funding
- Acknowledgement
- External Funding